- Home
- GGB vs HALO Comparison
GGB vs HALO Comparison
Compare GGB & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GGB | HALO |
|---|---|---|
| Founded | 1901 | 1998 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.8B |
| IPO Year | 2000 | 2001 |
Fundamental Metrics
Financial Performance| Metric | GGB | HALO |
|---|---|---|
| Price | $4.32 | $69.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $5.05 | ★ $78.18 |
| AVG Volume (30 Days) | ★ 21.5M | 1.2M |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.39% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.56 |
| Revenue | N/A | ★ $151,862,000.00 |
| Revenue This Year | $4.44 | $28.24 |
| Revenue Next Year | $3.52 | $12.56 |
| P/E Ratio | ★ $13.89 | $26.03 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.49 | $47.50 |
| 52 Week High | $4.66 | $82.22 |
Technical Indicators
Market Signals| Indicator | GGB | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 72.68 | 59.68 |
| Support Level | $4.13 | $67.94 |
| Resistance Level | $4.66 | $71.53 |
| Average True Range (ATR) | 0.10 | 1.83 |
| MACD | 0.08 | 0.73 |
| Stochastic Oscillator | 90.77 | 96.73 |
Price Performance
Historical ComparisonAbout GGB Gerdau S.A.
Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutors, mechanical construction bars, and reinforced steel locks. The company's geographical segment includes Brazil Operations; North America Operations; South America Operations as well as Special Steel Operations. It derives the majority of its revenue from the Brazil Operations segment.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.